ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAA4. A total of 40 filers reported holding ACORDA THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $66,000 | +8.2% | 87,000 | +16.0% | 0.00% | – |
| Q3 2016 | $61,000 | -7.6% | 75,000 | 0.0% | 0.00% | – |
| Q2 2016 | $66,000 | -1.5% | 75,000 | 0.0% | 0.00% | – |
| Q1 2016 | $67,000 | -22.1% | 75,000 | 0.0% | 0.00% | – |
| Q4 2015 | $86,000 | +26.5% | 75,000 | 0.0% | 0.00% | – |
| Q3 2015 | $68,000 | -10.5% | 75,000 | 0.0% | 0.00% | – |
| Q2 2015 | $76,000 | – | 75,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 4,000,000 | $4,603,000 | 2.85% |
| LINDEN ADVISORS LP | 9,910,000 | $11,427,000 | 2.16% |
| Context Capital Management, LLC | 1,500,000 | $1,725,000 | 2.14% |
| Mohican Financial Management, LLC | 3,500,000 | $4,027,000 | 1.98% |
| Sage Capital Management, LLC | 1,570,000 | $1,801,000 | 1.94% |
| SYMPHONY ASSET MANAGEMENT LLC | 12,771,000 | $14,695,000 | 1.83% |
| GRACE BROTHERS MANAGEMENT LLC | 1,500,000 | $1,727,000 | 1.66% |
| Fore Research & Management, LP | 24,095,000 | $27,844,000 | 1.51% |
| Wellesley Asset Management | 16,163 | $18,690,000 | 1.10% |
| BASSO CAPITAL MANAGEMENT, L.P. | 5,500,000 | $6,332,000 | 1.01% |